1. Home
  2. DGICB vs SION Comparison

DGICB vs SION Comparison

Compare DGICB & SION Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DGICB
  • SION
  • Stock Information
  • Founded
  • DGICB 1986
  • SION 2019
  • Country
  • DGICB United States
  • SION United States
  • Employees
  • DGICB N/A
  • SION N/A
  • Industry
  • DGICB Property-Casualty Insurers
  • SION
  • Sector
  • DGICB Finance
  • SION
  • Exchange
  • DGICB Nasdaq
  • SION NYSE
  • Market Cap
  • DGICB 588.8M
  • SION 583.9M
  • IPO Year
  • DGICB N/A
  • SION 2025
  • Fundamental
  • Price
  • DGICB $15.86
  • SION $12.49
  • Analyst Decision
  • DGICB
  • SION Strong Buy
  • Analyst Count
  • DGICB 0
  • SION 1
  • Target Price
  • DGICB N/A
  • SION $32.00
  • AVG Volume (30 Days)
  • DGICB 1.8K
  • SION 264.7K
  • Earning Date
  • DGICB 04-24-2025
  • SION 03-20-2025
  • Dividend Yield
  • DGICB 3.56%
  • SION N/A
  • EPS Growth
  • DGICB 1026.10
  • SION N/A
  • EPS
  • DGICB 1.50
  • SION N/A
  • Revenue
  • DGICB $989,605,050.00
  • SION N/A
  • Revenue This Year
  • DGICB N/A
  • SION N/A
  • Revenue Next Year
  • DGICB $4.06
  • SION N/A
  • P/E Ratio
  • DGICB $12.61
  • SION N/A
  • Revenue Growth
  • DGICB 6.71
  • SION N/A
  • 52 Week Low
  • DGICB $10.75
  • SION $11.25
  • 52 Week High
  • DGICB $18.50
  • SION $25.19
  • Technical
  • Relative Strength Index (RSI)
  • DGICB 68.19
  • SION N/A
  • Support Level
  • DGICB $14.36
  • SION N/A
  • Resistance Level
  • DGICB $15.47
  • SION N/A
  • Average True Range (ATR)
  • DGICB 0.67
  • SION 0.00
  • MACD
  • DGICB 0.18
  • SION 0.00
  • Stochastic Oscillator
  • DGICB 100.00
  • SION 0.00

About DGICB Donegal Group Inc. Class B

Donegal Group Inc is an insurance holding company that offers businesses and individuals personal and commercial lines of property and casualty insurance. The company's reportable segments are its Investment function, Personal lines of insurance, and Commercial lines of insurance. Personal lines products consist mainly of homeowners and private passenger automobile policies. The Commercial lines products of its insurance subsidiaries consist mainly of commercial automobile, commercial multi-peril, and workers' compensation policies. The group mainly operates in the United States.

About SION SIONNA THERAPEUTICS INC

Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein to deliver clinically meaningful benefit to CF patients. CF is a progressive and life-threatening genetic disease caused by inherited mutations in the CFTR gene, which Heads to insufficient CFTR function.

Share on Social Networks: